Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 30:5:223-34.
doi: 10.2147/CEOR.S39634. Print 2013.

Medical technology as a key driver of rising health expenditure: disentangling the relationship

Affiliations

Medical technology as a key driver of rising health expenditure: disentangling the relationship

Corinna Sorenson et al. Clinicoecon Outcomes Res. .

Abstract

Health care spending has risen steadily in most countries, becoming a concern for decision-makers worldwide. Commentators often point to new medical technology as the key driver for burgeoning expenditures. This paper critically appraises this conjecture, based on an analysis of the existing literature, with the aim of offering a more detailed and considered analysis of this relationship. Several databases were searched to identify relevant literature. Various categories of studies (eg, multivariate and cost-effectiveness analyses) were included to cover different perspectives, methodological approaches, and issues regarding the link between medical technology and costs. Selected articles were reviewed and relevant information was extracted into a standardized template and analyzed for key cross-cutting themes, ie, impact of technology on costs, factors influencing this relationship, and methodological challenges in measuring such linkages. A total of 86 studies were reviewed. The analysis suggests that the relationship between medical technology and spending is complex and often conflicting. Findings were frequently contingent on varying factors, such as the availability of other interventions, patient population, and the methodological approach employed. Moreover, the impact of technology on costs differed across technologies, in that some (eg, cancer drugs, invasive medical devices) had significant financial implications, while others were cost-neutral or cost-saving. In light of these issues, we argue that decision-makers and other commentators should extend their focus beyond costs solely to include consideration of whether medical technology results in better value in health care and broader socioeconomic benefits.

Keywords: costs; health expenditure; health policy; medical technology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Total expenditure on health as a percentage of gross domestic product (GDP) (1980–2009). Notes: *All data from 1980 except for Czech Republic (1990), Hungary (1991), Italy (1998), Poland (1990), and Slovenia (1995); **all data from 2009, except for Portugal (2008). OECD Health Data 2011.

Similar articles

Cited by

References

    1. Organisation for Economic Co-operation and Development . OECD Health Data 2011. Paris, France: Organisation for Economic Co-operation and Development; 2011. Available from http://www.oecd.org/health/health-systems/healthataglance2011.htm.
    1. Lubitz JD, Riley GF. Trends in Medicare payments in the last year of life. N Engl J Med. 1993;328:1092–1096. - PubMed
    1. Organisation for Economic Co-operation and Development . OECD Health at a Glance: Europe 2010. Paris, France: Organisation for Economic Co-operation and Development; 2010.
    1. Organisation for Economic Co-operation and Development Projecting OECD Health and Long Term Care Expenditures: What are the Main Drivers? Organisation for Economic Co-operation and Development Economic Department Working Paper, No 477; 2006. Available from: http://www.oecd.org/tax/public-finance/36085940.pdf. Accessed March 15, 2013. - PubMed
    1. Centers for Disease Control and Prevention . Health, United States, 2009 with Special Feature on Medical Technology. US Department of Health and Human Services; Hyattsville, MD: 2009. Available from: http://www.cdc.gov/nchs/data/hus/hus09.pdf. Accessed March 15, 2013.

Appendix 1

Studies reviewed
    1. Aidelsburger P, Grabein K, Klauss V, Wasem J. Cost-effectiveness of cardiac resynchronization therapy in combination with an implantable cardioverter defibrillator (CRT-D) for the treatment of chronic heart failure from a German health care system perspective. Clin Res Cardiol. 2002;97:89–97. - PubMed
    1. Baker L, Spetz J. Managed Care and Medical Technology Growth. 1999 National Bureau of Economic Research Working Paper Series, No 6894. Available from: http://www.nber.org/chapters/c9845.pdf. Accessed March 17, 2013.
    1. Baker LC. Managed care and technology adoption in health care: evidence from magnetic resonance imaging. J Health Econ. 2001;20:395–421. - PubMed
    1. Baker L, Birnbaum H, Geppert J, Mishol D, Moyneur E. The relationship between technology availability and health care spending. Health Aff (Millwood) 2003;(Suppl Web Exclusives):W3-537–51. - PubMed
    1. Bakhai A, Stone GW, Grines CL, et al. Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. Circulation. 2003;108:2857–2863. - PubMed

LinkOut - more resources